Health Imaging | Homepage

John Simon, MD, CEO of SimonMed Imaging, one of the largest U.S. outpatient medical imaging providers and physician radiology practices, is a big advocate for whole-body MRI screening, but there are some radiologists who are against this type of screening. He offered a comprehensive look at whole-body screenings.

SimonMed Imaging CEO discusses why his radiology practice offers elective whole-body MRIs

John Simon, MD, is a big advocate for these elective exams, but the American College of Radiology and some members of the specialty oppose this practice.

CT scanner screens for cardiovascular disease and lung cancer with single image.

FDA clears cardiac CT scanner for low-dose lung cancer screening

The scanner can complete two life-saving imaging acquisitions with a single pass.

FDA clears 1st blood test for Alzheimer’s, reducing need for ‘costly’ PET imaging

The “Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio” test is indicated for the early detection of amyloid plaques, a hallmark sign of the neurodegenerative disease.

CDC investigating outbreak linked to contaminated ultrasound gel used in image-guided procedures

Authorities issued three recommendations for radiologists related to the issue, including avoiding the use of nonsterile US gels.

ACR suggests 5 ways White House can ease regulatory burden on radiologists

The college's suggestions came in response to a recent request for information, seeking regulations that "stifle American businesses."

MRI death scene in Final Destination Bloodlines is technically impossible.

'Technically impossible' MRI death scene in new horror flick sparking irrational fears of routine imaging

After watching the scene, many movie fanatics took to social media platforms to express their newfound fears related to MRI scanners.

Innovation at work

Radiology Business

Bayer: Helping Customers Sustain Patient Care Amid Market Disruptions

As radiology departments across the US continue to navigate the complexities of the current imaging market, including disruptions in supply chains and increased demand for CT contrast media, one constant remains: the need for reliable, quality supply partners to help sustain patient care.

Around the web

Cardiovascular Business

AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.